Price T Rowe Associates Inc Kinnate Biopharma Inc. Transaction History

Price T Rowe Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$17.81 - $24.87 $7.93 Million - $11.1 Million	-445,477 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$22.19 - $31.55 $4.51 Million - $6.41 Million	-203,305 Reduced 31.34%	445,477 $10.4 Million
Q1 2021 May 17, 2021	SELL	$26.99 - $40.0 $16,841 - $24,960	-624 Reduced 0.1%	648,782 $20.2 Million
Q4 2020 Feb 16, 2021	BUY	$36.35 - $45.25 $23.6 Million - $29.4 Million	649,406 New	649,406 $25.8 Million

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.